<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of the management and prognosis of patients with Fontan circulation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of the management and prognosis of patients with Fontan circulation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of the management and prognosis of patients with Fontan circulation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Johnson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gruschen Veldtman, MBChB, FRCP, Dip Obst</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2984338047"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The Fontan operation is a palliative surgical procedure performed in patients with a functional or anatomic single ventricle (also known as univentricular heart) [<a href="#rid1">1,2</a>]. The Fontan operation was originally described for patients with tricuspid atresia in 1971 [<a href="#rid3">3</a>]. During the past 50 years, the types of malformations for which the Fontan operation is utilized has expanded considerably, and it has become the most common operation performed for patients with any type of single ventricle [<a href="#rid4">4</a>]. Following the Fontan procedure, patients face substantial morbidity and mortality risk and require lifelong follow-up with a cardiologist experienced in the care of patients with complex congenital heart disease (eg, pediatric cardiologist or adult congenital heart disease specialist).</p><p>This topic will discuss management of patients who have undergone a Fontan procedure. Lesions for which a Fontan may be performed are discussed in separate topic reviews. Complications in patients with Fontan circulation are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation"</a>.)</p><p class="headingAnchor" id="H3112384591"><span class="h1">BACKGROUND OF FONTAN PROCEDURE</span></p><p class="headingAnchor" id="H2110453634"><span class="h2">Lesions treated and rationale</span><span class="headingEndMark"> — </span>The Fontan procedure is typically performed in patients with anatomic or functional single ventricle, defined as presence of only one well-developed ventricle with the rudimentary ventricle (if present) less than 30 percent of its expected volume. Depending on the underlying anatomy, the predominant chamber could be either a left or right ventricle, both right and left ventricles, or in rare cases indeterminate. Lesions for which a Fontan may be performed include:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypoplastic left heart syndrome. (See  <a class="medical medical_review" href="/z/d/html/14370.html" rel="external">"Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tricuspid atresia. (See  <a class="medical medical_review" href="/z/d/html/14587.html" rel="external">"Tricuspid valve atresia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary atresia with intact ventricular septum. (See  <a class="medical medical_review" href="/z/d/html/87462.html" rel="external">"Pulmonary atresia with intact ventricular septum (PA/IVS)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Double-inlet left ventricle.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Unbalanced atrioventricular canal defects. (See  <a class="medical medical_review" href="/z/d/html/86278.html" rel="external">"Management and outcome of atrioventricular (AV) canal defects"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rarely, a Fontan operation may be performed for patients with other conditions such as Ebstein anomaly, double-outlet right ventricle, congenitally corrected transposition of the great arteries, or other anatomic variants in which there is significant hypoplasia of either ventricle.</p><p></p><p>The single functional ventricle must supply blood to the higher resistance systemic circulation, as well as provide blood flow to the lower resistance pulmonary circulation in order to support long-term survival. This balance of the circulations occurs spontaneously only rarely, and surgical modification of the circulation is usually required.</p><p>The Fontan procedure, in its varied forms, effectively diverts systemic venous return to the lungs without a pump. Pulmonary blood flow is driven by central venous pressure and is augmented by changes in intrathoracic pressure, active relaxation of the systemic ventricle (drawing blood forward), and the peripheral skeletal muscle pump [<a href="#rid5">5</a>]. For this circulation to be effective, the patient must have a low pulmonary arteriolar resistance, relatively normal systolic and diastolic function of the single ventricle, and sufficiently large pulmonary arteries to minimize mechanical resistance [<a href="#rid6">6,7</a>].</p><p>The worldwide population of patients with Fontan circulation was estimated to be 50,000 to 70,000 patients as of 2018, with 40 percent of patients over 18 years of age [<a href="#rid1">1,8</a>]. In the United States, about 1000 Fontan operations are performed annually [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H2567288850"><span class="h2">Criteria for Fontan procedure</span><span class="headingEndMark"> — </span>Accepted contemporary criteria for the Fontan procedure are similar to the requirements for an "ideal Fontan candidate" originally specified by Dr. Fontan and colleagues [<a href="#rid3">3</a>], although some criteria such as age and pulmonary artery anatomy requirements have been liberalized; others, such as pulmonary vascular resistance, have become more stringent [<a href="#rid10">10</a>].</p><p>Common criteria for the Fontan procedure include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Age. The Fontan operation is currently typically performed in those between two and five years of age, with a weight of around 10 to 15 kg, depending on the specific clinical presentation, surgical history, and center preference. While some centers perform the Fontan procedure in those between two and three years of age in an attempt to limit the amount of time the patient is cyanosed, others wait until there is physiologic need (eg, decreasing oxygen saturations, symptoms), often between three and five years of age [<a href="#rid11">11</a>]. Although the Fontan operation in early childhood is preferred, it is also an option in carefully selected adults with functional single ventricle [<a href="#rid12">12</a>]. The current flexibility in age criteria contrasts with the original commandments, which specified ages 4 to 15 years [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sinus rhythm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal drainage of the venae cavae. While normal drainage of the venae cavae was one of the original commandments, modifications of the Fontan procedure have been published for use in patients with an interrupted inferior vena cava. The most popular of these is the Kawashima procedure [<a href="#rid13">13</a>]. In patients with bilateral superior vena cavae, bilateral Glenn anastomosis can also be performed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal right atrial volume.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Low pulmonary artery pressure (&lt;15 mmHg).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Low pulmonary resistance (&lt;4 Woods units/m<sup>2</sup>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adequate pulmonary artery size (pulmonary-artery-to-aorta ratio &gt;0.75).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal ventricular function.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No/minimal atrioventricular valve regurgitation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal pulmonary artery anatomy without distortion.</p><p></p><p class="headingAnchor" id="H1686866922"><span class="h2">Technical surgical issues</span></p><p class="headingAnchor" id="H438118767"><span class="h3">Common surgeries prior to the Fontan procedure</span><span class="headingEndMark"> — </span>When evaluating a patient who has had a Fontan procedure, a detailed surgical history is critically important, including a review of all past operative notes, as this enhances insight into the specific physiology of the individual Fontan patient. The unfenestrated Fontan procedure returns the patient to near normal oxygen saturations by fully separating the pulmonary and systemic circulations and aims to return the systemic ventricle to a near-normal workload. The vast majority of patients (particularly those having the Fontan procedure since 1990) will have had at least one prior palliative procedure. The following are surgeries that patients may have received prior to the Fontan procedure:</p><p class="bulletIndent1"><span class="glyph">●</span>Bidirectional cavopulmonary anastomosis (bidirectional Glenn connection  (<a class="graphic graphic_figure graphicRef95319" href="/z/d/graphic/95319.html" rel="external">figure 1</a>)). (See  <a class="medical medical_review" href="/z/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome", section on 'Stage II: Cavopulmonary shunt'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic-pulmonary shunts (eg, Blalock-Thomas-Taussig shunt [also commonly called Blalock-Taussig shunt], central shunts [eg, Potts, Waterston, Mee])  (<a class="graphic graphic_figure graphicRef98391 graphicRef98327 graphicRef98328" href="/z/d/graphic/98391.html" rel="external">figure 2A-C</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Atrial septectomy or septostomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Norwood operation (performed for hypoplastic left heart syndrome and other patients with left ventricular hypoplasia)  (<a class="graphic graphic_figure graphicRef81022" href="/z/d/graphic/81022.html" rel="external">figure 3</a>). This includes staged reconstruction to allow unobstructed flow from the systemic right ventricle to aortic arch and coronary arteries; thus, the stages include aortic arch repair, relief of obstruction to pulmonary venous return (if present), and shunt placement from either right ventricle to pulmonary artery or a modified Blalock-Thomas-Taussig shunt. (See  <a class="medical medical_review" href="/z/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome", section on 'Stage I procedures'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Damus-Kaye-Stansel (DKS) procedure (generally performed at the time of cavopulmonary connection for variants of hypoplastic left heart syndrome and other forms of single-ventricle physiology with transposed great arteries and/or systemic outflow obstruction). The DKS procedure involves a direct connection of the ascending aorta and main pulmonary artery, with the intent of having both outflows directed to the systemic circulation, as a method for mitigating the risk of systemic ventricular outflow tract obstruction. A separate conduit or shunt is then placed to provide blood flow to the pulmonary circulation. (See  <a class="medical medical_review" href="/z/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome", section on 'Surgical management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Starnes procedure (performed for severe Ebstein anomaly; the procedure includes patch closure of the tricuspid valve annulus, atrial septectomy, and placement of a systemic-pulmonary shunt). (See  <a class="medical medical_review" href="/z/d/html/8146.html" rel="external">"Ebstein anomaly: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary arterial banding.</p><p></p><p class="headingAnchor" id="H3973375387"><span class="h3">Surgical technique</span><span class="headingEndMark"> — </span>The most prevalent forms of the Fontan procedure seen in pediatric and adult cardiology clinics are the atriopulmonary (or "classic") connection and cavopulmonary connection  (<a class="graphic graphic_figure graphicRef95320" href="/z/d/graphic/95320.html" rel="external">figure 4</a>). The atriopulmonary connection has been abandoned in favor of cavopulmonary connections that avoid progressive atrial dilation and associated complications such as arrhythmias and thrombus formation [<a href="#rid1">1</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In the atriopulmonary Fontan, the right atrial appendage is directly anastomosed to the main pulmonary artery, providing a pathway for blood from the inferior and superior venae cavae to get to the pulmonary circulation  (<a class="graphic graphic_figure graphicRef95320" href="/z/d/graphic/95320.html" rel="external">figure 4</a>). The atrial septum is left intact (or repaired), and there should be no shunting between the right (deoxygenated blood) and the left atrium (oxygenated blood).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The cavopulmonary connection was first described by de Leval in 1988 and uses either an intraatrial conduit in the form of a lateral tunnel (incorporating part of the native right atrium in the pathway) or extracardiac conduit  (<a class="graphic graphic_figure graphicRef95320" href="/z/d/graphic/95320.html" rel="external">figure 4</a>) [<a href="#rid14">14,15</a>]; the latter was described by Marcelletti [<a href="#rid16">16</a>]. This completes the "total cavopulmonary connection" and can be done as the initial operation in combination with or after a bidirectional Glenn anastomosis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Since the year 2000, the majority of patients undergoing a Fontan procedure have had a nonvalved extracardiac conduit placed [<a href="#rid1">1,4,11</a>]; the surgical procedure and material used for the conduit vary among institutions. These extracardiac conduits typically vary in diameter (from 18 to 22 mm) and are placed in the pericardial space. This type of connection is generally preferred since it minimizes native atrial tissue in the Fontan pathway.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An intraatrial conduit may still be used when pulmonary venous or other anomalies complicate the use of an extracardiac conduit.</p><p></p><p>Indications for reoperation (including conversion surgery and other types of reoperation) are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Indications for reintervention'</a>.)</p><p class="headingAnchor" id="H2290923928"><span class="h3">Fenestration</span><span class="headingEndMark"> — </span>In selected cases, a fenestration in the Fontan is either left or created, functioning as a small residual atrial septal defect. This allows a small right-to-left shunt to persist between the Fontan connection and the left atrium. Given the potential benefits and risks of fenestration, some centers have moved toward using fenestration only in "high-risk" patients [<a href="#rid17">17-19</a>]. This commonly includes patients with mildly elevated pulmonary pressure or vascular resistance, those with abnormal pulmonary artery anatomy, and patients with other risks for protein-losing enteropathy (PLE). The decision remains largely center specific. Management of patients with PLE is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Protein-losing enteropathy'</a>.)</p><p>A fenestration eases the transition to the Fontan circulation for patients by providing a consistent source of systemic ventricular preload. Secondary benefits of fenestration include reported decreased duration of postoperative pleural effusions and diminished postoperative hospital length of stay [<a href="#rid20">20,21</a>].</p><p>Potential risks of fenestration include paradoxical embolization due to the right-to-left shunt, (thus, anticoagulation is suggested for Fontan patients with fenestration), desaturation from right-to-left shunting, and the potential need for future percutaneous procedures to close the fenestration.</p><p>Spontaneous fenestration closure occurs frequently. If the patient has acceptable post-Fontan-procedure hemodynamics, spontaneous fenestration closure may not result in any sequelae and may be found during routine follow-up.</p><p class="headingAnchor" id="H510735417"><span class="h2">Fontan "physiology"</span><span class="headingEndMark"> — </span>Following Fontan procedure, since there is no ventricular pump to propel blood into the pulmonary arterial circulation, systemic venous pressures become elevated compared with those of a normal biventricular circulation  (<a class="graphic graphic_figure graphicRef95254" href="/z/d/graphic/95254.html" rel="external">figure 5</a>) [<a href="#rid22">22</a>]. Thus, individuals with Fontan circulation may have heart failure signs and symptoms in the presence of preserved ventricular function, as well as those associated with systolic and/or diastolic dysfunction [<a href="#rid1">1</a>]. Many of the complications seen post-Fontan procedure are directly or indirectly related to this chronic elevation of central venous pressure. Cardiac output is also typically lower than normal in individuals with two-ventricle circulation, particularly during physical exertion. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation"</a>.)</p><p>Patients with Fontan circulation generally have mild systemic arterial oxygen desaturation at rest on room air (oxygen saturation most commonly 90 to 95 percent) for a number of reasons [<a href="#rid1">1</a>]. After a cavopulmonary Fontan procedure, deoxygenated coronary sinus blood is typically left draining into the atrial chamber, which connects directly to the systemic ventricle and systemic circulation. Also, ventilation-perfusion mismatch is caused by pulmonary arterial blood flow with low kinetic energy gravitating to lower lung segments, while upper segments receive greater aeration.</p><p>Some patients are left with fenestrations that allow right-to-left shunting and decrease oxygen saturation. Intra- or extracardiac communications (eg, veno-venous collaterals and pulmonary arteriovenous fistula) between the systemic venous and lower-pressure pulmonary venous chambers may develop over time. Some patients with Fontan circulation have marked arterial oxygen desaturation (&lt;90 percent) at rest, as discussed separately. (See <a class="local">'Surgical technique'</a> above and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Cyanosis and shunts'</a>.)</p><p class="headingAnchor" id="H1785234370"><span class="h1">LONG-TERM FOLLOW-UP</span></p><p class="headingAnchor" id="H1310214252"><span class="h2">Follow-up recommendations</span><span class="headingEndMark"> — </span>Patients with prior Fontan operation require lifelong follow-up with a cardiologist experienced in the care of patients with complex congenital heart disease (eg, pediatric cardiologist or adult congenital heart disease specialist) [<a href="#rid1">1,2</a>]. Annual clinical evaluation by a specialist is recommended at a minimum. Patients after the Fontan operation are among the most challenging that congenital cardiologists manage due to the high level of complexity of issues involved and substantial risk for morbidity and mortality. Patients with complications following Fontan operation require more frequent follow-up; the frequency of follow-up and monitoring is individualized. The medical care team should include a primary care provider and, if the patient does not live close to a congenital heart disease center, ideally also should include a local cardiologist to provide combined care with a congenital heart disease specialist.</p><p>Fontan patients are best considered as having a condition with systemic and cardiac manifestations. Specialized care of the patient following Fontan operation should include [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical assessment by a congenital cardiologist every 6 to 12 months, depending on comorbid conditions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Regular laboratory testing including hematology, B-type natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP), renal function (including urine for protein content), liver function (including liver function tests [LFTs], platelet count, international normalized ratio [INR], and alpha-fetoprotein), electrolyte assessment, serum albumin, and total protein (to screen for protein-losing enteropathy [PLE]). Frequency depends on the time since the Fontan operation. American Heart Association (AHA) guidelines suggest testing every three to four years in patients &lt;12 years old, every one to three years in adolescence, and every one to two years in adulthood. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Protein-losing enteropathy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Annual electrocardiogram (ECG) is recommended to evaluate heart rhythm.</p><p></p><p class="bulletIndent1">If symptoms, tachycardia, or an abnormal ECG develop, further arrhythmia assessment may include Holter monitoring, event monitoring, prolonged rhythm assessment, or exercise ECG to assess heart rate response and heart rhythm with exercise.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Annual chest radiography is generally suggested. The heart size and pulmonary vascularity should be normal in patients following Fontan operation. Pleural effusions suggest PLE or other hemodynamic abnormality. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Heart failure'</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Protein-losing enteropathy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiopulmonary exercise testing is performed regularly (every one to three years, depending upon the age of the patient [<a href="#rid1">1</a>]) to identify changes in exercise capacity, arrhythmias, or desaturation with exercise that may prompt further evaluation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Overnight oximetry may be performed to screen for obstructive sleep apnea, as this condition is common in adolescent and adult patients with Fontan circulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac imaging:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Annual comprehensive transthoracic echocardiography (TTE) is recommended and should be performed by staff with expertise in congenital heart disease to assess ventricular function, valve function, and the Fontan connection.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Transesophageal echocardiography (TEE; or cross-sectional imaging) may be performed if right atrial or Fontan thrombus is suspected, and provides improved visualization of the entire Fontan pathway. TEE examination may help to assess the presence or absence of a Fontan fenestration and the gradient across the fenestration if present and not seen on TTE. TEE is recommended prior to cardioversion in patients following Fontan regardless of anticoagulation status. Given the risk associated with a TEE procedure and sedation for the procedure, TEE should be performed only when needed and by staff with expertise in complex congenital heart disease. In some centers a cardiac anesthesiologist provides sedation for high-risk patients.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiovascular magnetic resonance (CMR) imaging/computed tomography (CT) – If echocardiography images are inadequate or inconclusive, additional imaging with cardiac CT or CMR is performed on an individual basis by staff with expertise in congenital heart disease. AHA guidelines suggest that CMR could be performed as often as every two to three years in Fontan patients, although many congenital centers do not utilize CMR this frequently.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiac catheterization is indicated to investigate unexplained volume retention, fatigue, exercise limitation, arrhythmias, cyanosis, hemoptysis, PLE, failing Fontan physiology, and features of Fontan-associated liver disease [<a href="#rid2">2</a>]. AHA guidelines suggest performing a cardiac catheterization at minimum every 10 years after the Fontan operation. Exercise during cardiac catheterization may enhance assessment of abnormal hemodynamics and provide incremental diagnostic information [<a href="#rid23">23,24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal imaging – Patients with Fontan-associated liver disease with cirrhosis or marked fibrosis need regular abdominal imaging to assess liver disease, spleen size, ascites, and to assess for hepatocellular carcinoma.</p><p></p><p class="headingAnchor" id="H4235176735"><span class="h2">Findings requiring further evaluation</span><span class="headingEndMark"> — </span>Symptoms, signs, and laboratory tests may alert the clinician to complications following Fontan procedure. Acute decompensation can occur in patients post-Fontan and generally is precipitated by a tachy- or bradyarrhythmia or Fontan pathway thrombosis. When patients present with acute symptoms, Fontan pathway obstruction or stenosis should be sought.</p><p>Important hemodynamic issues contributing to chronic morbidity and mortality in patients with Fontan operation include progressive symptoms, decline in systemic ventricular function, greater ventricular volumes, valve regurgitation, a rise in pulmonary vascular resistance, atrial enlargement, atrial arrhythmias, pulmonary venous obstruction, and chronic systemic venous hypertension, which can lead to hepatic congestion and dysfunction [<a href="#rid25">25</a>]. Echocardiography-derived circumferential strain and CMR-derived ventricular end-diastolic volume index are associated with transplant-free survival in patients after Fontan operation and have higher discriminative ability than clinical variables [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H3664104255"><span class="h3">Symptoms</span><span class="headingEndMark"> — </span>New symptoms and signs that warrant investigation after Fontan operation include palpitations/arrhythmias, syncope or near-syncope, dyspnea, fatigue, exercise intolerance, poor somatic growth, diarrhea, and edema or ascites. Such symptoms may be related to heart failure (due to Fontan circulation, ventricular dysfunction, arrhythmias, valve dysfunction, or volume-loading shunts), PLE, liver disease, or more complex conditions.</p><p class="headingAnchor" id="H2468620637"><span class="h3">Physical examination findings</span><span class="headingEndMark"> — </span>The physical examination is helpful in identifying complications following Fontan procedure.</p><p>Since patients with Fontan circulation are at risk for impaired physical development, patient growth (including height and weight), pubertal development, and muscle mass should be evaluated. Mild jugular venous distention (usually nonpulsatile) is common after the cavopulmonary Fontan procedure, and prominent A waves can often be seen in atriopulmonary Fontan procedure. However, marked jugular venous distension and hepatomegaly should raise concern for Fontan obstruction.</p><p>Prior shunts may affect the physical examination. In patients with prior Blalock-Thomas-Taussig (subclavian artery to pulmonary artery) shunt  (<a class="graphic graphic_figure graphicRef98391" href="/z/d/graphic/98391.html" rel="external">figure 2A</a>), falsely low or absent ipsilateral upper-extremity blood pressure readings may be obtained, particularly in the setting of a classic Blalock-Thomas-Taussig shunt. In patients with a history of a Glenn operation  (<a class="graphic graphic_figure graphicRef95319" href="/z/d/graphic/95319.html" rel="external">figure 1</a>), Fontan obstruction may manifest as hepatic distension and later peripheral edema, without jugular venous distention.</p><p>Cyanosis should be assessed following Fontan procedure. Patients with Fontan operation are not expected to be significantly cyanotic (&lt;90 percent) unless they have a Fontan fenestration or veno-venous collaterals. Cyanosis may worsen with physical activity. Cyanotic patients who have not received intentional fenestration should be referred for cardiac catheterization to determine the cause of cyanosis. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Cyanosis and shunts'</a>.)</p><p>The presence of edema or ascites should prompt assessment for cardiac dysfunction, Fontan obstruction, PLE, or liver disease. Lower extremity venous insufficiency is commonly seen during late follow-up, particularly those with prior multiple cardiac catheterizations and/or a history of deep vein thrombosis. Identification of those at greatest risk for local trauma and bleeding from the peripheral varicosities is important to securing good outcomes.</p><p class="headingAnchor" id="H3589328873"><span class="h3">Laboratory findings</span><span class="headingEndMark"> — </span>Low serum albumin or total protein should prompt evaluation for PLE or other causes of protein loss. Patients with evidence of kidney disease (elevated creatinine, cystatin-C, and/or reduced glomerular filtration rate), PLE, or liver disease (abnormal LFTs, thrombocytopenia, elevated INR) should receive further evaluation and referral to nephrology and gastrointestinal/hepatology specialists with experience treating patients with complications following Fontan operation. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Renal complications'</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Liver disease'</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Arrhythmias'</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Protein-losing enteropathy'</a>.)</p><p class="headingAnchor" id="H768356621"><span class="h3">Imaging findings</span><span class="headingEndMark"> — </span>Echocardiography may identify systemic ventricular dysfunction. This is typically assessed using a combination of qualitative and quantitative measures. Changes in ventricular function should prompt consideration for further evaluation (eg, catheterization or advanced imaging) and addition of heart failure therapies. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Heart failure'</a>.)</p><p>Atrioventricular and semilunar valve disease are also assessed routinely by TTE, and the presence of severe valve disease may prompt further intervention. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Atrioventricular valve regurgitation'</a>.)</p><p>Intracardiac thrombus is sought routinely, especially those with arrhythmias and/or atriopulmonary Fontan procedure with associated right atrial dilation. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Thrombosis'</a>.)</p><p>Aortic dilation may be noted in select patient populations following Fontan procedure.</p><p>Echocardiography with Doppler and other imaging modalities may identify obstruction at any point in the Fontan circuit. If suspected, cardiac catheterization will be required to confirm and determine best treatment options. Since echocardiography and other imaging may miss Fontan obstruction, cardiac catheterization is the diagnostic test of choice when obstruction is suspected. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Cardiovascular complications'</a>.)</p><p class="headingAnchor" id="H1305896896"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H4166560966"><span class="h2">Management of complications</span><span class="headingEndMark"> — </span>Prevention and management of complications in patients with Fontan circulation (including use of antithrombotic agents, given the risk of thrombus and thromboembolism) are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation"</a>.)</p><p class="headingAnchor" id="H2876107432"><span class="h2">Management of noncardiac surgery</span><span class="headingEndMark"> — </span>Patients with Fontan circulation are at increased risk of anesthetic and perioperative complications, including death. Elective noncardiac surgical procedures should be performed at experienced centers, and an experienced multidisciplinary team should manage Fontan patients. The highest-risk patients appear to be those with ventricular dysfunction, protein-losing enteropathy, and Fontan-associated liver disease [<a href="#rid27">27,28</a>]. (See  <a class="medical medical_review" href="/z/d/html/6615.html" rel="external">"Management of cardiac risk for noncardiac surgery"</a> and  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery"</a>.)</p><p class="headingAnchor" id="H3184690648"><span class="h2">Endocarditis prophylaxis</span><span class="headingEndMark"> — </span>Endocarditis prophylaxis is routinely recommended for patients at the highest risk of adverse effects from endocarditis; this includes patients with Fontan circulation, given the presence of a prosthetic conduit and passive flow [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">"Prevention of endocarditis: Antibiotic prophylaxis and other measures"</a>.)</p><p>Antibiotic prophylaxis is suggested for patients with Fontan operation for all designated relevant procedures; these include dental procedures that involve manipulation of gingival tissue, the periapical region of teeth, and perforation of the oral mucosa. (See  <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">"Prevention of endocarditis: Antibiotic prophylaxis and other measures"</a>.)</p><p class="headingAnchor" id="H92366496"><span class="h2">Exercise</span><span class="headingEndMark"> — </span>A significant (eg, 16 to 19 percent) increase in peak oxygen consumption has been reported after completion of the Fontan procedure [<a href="#rid29">29,30</a>]. Despite this improvement, post-Fontan-procedure patients remain limited in their physical abilities, with maximum oxygen consumption ranging from 48 to 65 percent of predicted values for age- and sex-matched peers [<a href="#rid31">31-33</a>]. The majority of children with Fontan circulation do not achieve normal physical activity levels [<a href="#rid34">34</a>], which may be due to multiple physical, social, and psychological factors. Physiologic causes of restricted exercise capacity in this population include cardiovascular, pulmonary, and muscular limitations. Cardiovascular impairments include failure to increase stroke volume with activity (related to reduced preload from failure to adequately increase pulmonary blood flow) [<a href="#rid31">31,35,36</a>], chronotropic incompetence, reduced arterial blood saturation (which may worsen with exercise) [<a href="#rid31">31,37,38</a>], and abnormal ventriculovascular coupling. Patients with Fontan circulation commonly have restrictive lung disease. Peak oxygen consumption is also affected by muscle mass [<a href="#rid39">39</a>]; 25 percent of Fontan patients have severely reduced muscle mass. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Cardiovascular complications'</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Respiratory complications'</a>.)</p><p>We suggest periodic cardiopulmonary exercise testing in patients following Fontan operation to exclude chronotropic incompetence, desaturation, or arrhythmias with exercise, and to assess whether exercise limitation is cardiac or pulmonary [<a href="#rid40">40</a>]. A regular exercise program is often suggested for patients following Fontan to reduce deconditioning, and some patients may benefit from a cardiac rehabilitation program [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Cardiovascular complications'</a> and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Respiratory complications'</a>.)</p><p>Oscillatory ventilation refers to regular oscillations in minute ventilation during cardiopulmonary exercise testing. Oscillatory ventilation has been found to predict mortality and arrhythmias independent of other known predictors in adults with heart failure. This is a relatively frequent occurrence in patients post-Fontan procedure and carries poor prognosis [<a href="#rid42">42</a>].</p><p>Patients with Fontan circulation should be encouraged to participate in an active lifestyle, including routine symptom-limited aerobic activity [<a href="#rid43">43,44</a>]. Competitive and isometric sports participation is generally discouraged, but recreational sports are encouraged. High-intensity resistance training can result in increased peak oxygen consumption, increased muscle strength, and total muscle mass.</p><p>The 2015 American College of Cardiology/American Heart Association (ACC/AHA) Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities provide a guideline for the Fontan patient interested in competitive sports participation [<a href="#rid45">45</a>]. These guidelines do not necessarily apply to noncompetitive sports activities. Patients are recommended to undergo full evaluation before competitive sports participation, including clinical assessment, ECG, imaging assessment of ventricular function (eg, echocardiography or magnetic resonance imaging), and cardiopulmonary exercise testing. The specific sports-based recommendations for Fontan patients include:</p><p class="bulletIndent1"><span class="glyph">●</span>Athletes without ventricular dysfunction, arrhythmias, or outflow tract obstruction "may be considered" for participation in moderate- to high-intensity sports. This is dependent on the athlete completing an exercise test with no exercise-induced arrhythmias, hypotension, or other concerning clinical symptoms [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Athletes with reduced ventricular function (ie, ejection fraction &lt;40 percent), outflow tract obstruction, or recurrent or uncontrolled arrhythmias are recommended to be restricted from sports, with the possible exception of class IA sports (these include golf, riflery, curling, bowling, yoga, and cricket).</p><p></p><p class="headingAnchor" id="H2414889951"><span class="h2">Reproductive issues</span><span class="headingEndMark"> — </span>Patients with prior Fontan procedure who are contemplating pregnancy should undergo preconception assessment and counseling by an adult congenital heart disease specialist, including a comprehensive prepregnancy cardiovascular evaluation to identify residua following Fontan operation that may adversely affect pregnancy outcome. A review of patient medications should be performed, including discussion of need and options for anticoagulation and discontinuation of medications that are harmful during pregnancy such as angiotensin converting enzyme inhibitors, angiotensin receptor blockers, angiotensin-neprilysin inhibitor, and direct oral anticoagulants. Prepregnancy counseling should also include a discussion about overall prognosis following Fontan procedure as well as genetic consultation. (See  <a class="medical medical_review" href="/z/d/html/1342.html" rel="external">"Use of anticoagulants during pregnancy and postpartum"</a> and  <a class="medical medical_review" href="/z/d/html/3507.html" rel="external">"Management of heart failure during pregnancy"</a>.)</p><p>Patients with poor functional capacity, a history of heart failure or ventricular function &lt;40 percent, arrhythmias, protein-losing enteropathy, intracardiac thrombi, Fontan-associated liver disease, or cyanosis (room air saturation &lt;90 percent) are discouraged from proceeding with pregnancy due to the risk of pregnancy-related complications and adverse fetal outcome [<a href="#rid46">46</a>].</p><p>Any pregnancy in a patient with prior Fontan operation is considered high risk. Successful pregnancy has been reported in Fontan patients, but complications are common and include atrial arrhythmias, thrombotic and bleeding events, ventricular dysfunction, and edema. There is an increased risk for spontaneous abortion and premature birth, as well as intrauterine growth restriction [<a href="#rid47">47-52</a>]. Postpartum hemorrhage is also well documented in up to 50 percent of pregnancies. Management of heart failure during pregnancy is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3507.html" rel="external">"Management of heart failure during pregnancy"</a>.)</p><p>A literature review reported rates of complications during 25 completed (&gt;20 weeks gestation) pregnancies among women with Fontan repair for various types of functional single ventricle [<a href="#rid51">51</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal arrhythmias occurred in four pregnancies, heart failure in one pregnancy, and cardiovascular events (myocardial infarction, stroke, cardiovascular mortality) in none.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>With respect to the fetus, preterm delivery occurred in seven pregnancies, fetal mortality in no pregnancies, perinatal mortality in one pregnancy and recurrent congenital heart disease (of any type) in one pregnancy.</p><p></p><p>Contraception in women with congenital heart disease is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1422.html" rel="external">"Pregnancy in women with congenital heart disease: General principles", section on 'Contraception'</a>.)</p><p class="headingAnchor" id="H1317989617"><span class="h2">Heart or multiorgan transplant</span><span class="headingEndMark"> — </span>An important part of the ultimate care of patients with Fontan palliation is discussion and evaluation for heart or multiorgan transplant as an ultimate treatment option. The timing of this evaluation should be individualized, but the prospect of transplant should be introduced early in the course of care, particularly for patients with multiorgan disease. This may require referral to a center with expertise in complex congenital heart disease transplantation and multiorgan transplant.</p><p class="headingAnchor" id="H3977708250"><span class="h2">Social work</span><span class="headingEndMark"> — </span>Social work assessment and support are beneficial for many patients and their families and caregivers following Fontan procedure. Regular follow-up with a social worker is recommended.</p><p class="headingAnchor" id="H3240121439"><span class="h2">Palliative care</span><span class="headingEndMark"> — </span>While survival in patients with Fontan circulation has improved, many patients continue to face shortened life expectancy, and death is not always preceded by a period of decline [<a href="#rid1">1</a>]. Thus, palliative care is important for patients with Fontan circulation, including timely discussion of end-of-life matters and advanced care planning (including encouraging completion of advance directives) in an age- and development-appropriate manner [<a href="#rid1">1</a>]. A patient's primary care physician may provide palliative care, with consultation with palliative care specialists as needed to optimally address the patient's symptoms, as well as the patient's and family's concerns. (See  <a class="medical medical_review" href="/z/d/html/2197.html" rel="external">"Overview of comprehensive patient assessment in palliative care"</a> and  <a class="medical medical_review" href="/z/d/html/3511.html" rel="external">"Palliative care for patients with advanced heart failure: Indications and systems of care"</a> and  <a class="medical medical_review" href="/z/d/html/110747.html" rel="external">"Palliative care for patients with advanced heart failure: Decision support and management of symptoms"</a>.)</p><p class="headingAnchor" id="H1525364846"><span class="h1">PROGNOSIS AFTER FONTAN PROCEDURE</span><span class="headingEndMark"> — </span>Operative and long-term survival after Fontan procedure have steadily improved [<a href="#rid1">1,53</a>]. Postoperative 15- to 20-year survival rates after Fontan procedure range from 60 to 85 percent [<a href="#rid25">25,54,55</a>]. Patients currently undergoing Fontan procedure are predicted to have a 30-year survival rate of approximately 85 percent [<a href="#rid1">1</a>].</p><p>Mortality has been shown to correlate with underlying diagnosis, but many other factors contribute:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 261 patients born before 1985, the actuarial event-free survival was 75 and 68 percent at 10 and 20 years post-Fontan procedure, respectively. Patients who survived the initial operation had an 83 percent survival rate at 20 years. Predictors of all-cause mortality or transplantation included a history of hypoplastic left heart syndrome, elevated right atrial/central venous pressures, and a history of protein-losing enteropathy [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/z/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome", section on 'Outcome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 216 patients who had Fontan operations for tricuspid atresia, the cumulative survival rate was 79 percent with a median of 13 years of follow-up [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/z/d/html/14587.html" rel="external">"Tricuspid valve atresia"</a>.)</p><p></p><p>Survival for patients with hypoplastic left heart syndrome who undergo a Fontan operation ranges from 72 to 85 percent at 10 years [<a href="#rid25">25,56,57</a>]. However, when taking into account the other surgeries required for these infants, the overall survival of any infant with hypoplastic left heart syndrome through all of their initial surgeries is only 50 to 70 percent at 10 years. This low overall survival rate is related to other patient-specific factors including genetic factors, gestational age, and location of delivery [<a href="#rid11">11,58</a>]. Mortality occurring between surgical stages (known as interstage mortality) contributes substantially to overall mortality [<a href="#rid59">59</a>].</p><p class="headingAnchor" id="H125054889"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/122280.html" rel="external">"Society guideline links: Congenital heart disease in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/112260.html" rel="external">"Society guideline links: Arrhythmias in adults"</a>.)</p><p class="headingAnchor" id="H1721621772"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>The Fontan procedure was developed to divert systemic venous return to the lungs in patients with an anatomic or functional single ventricle. For this circulation to be effective, the patients must have a low pulmonary arteriolar resistance, relatively normal systolic and diastolic function of the single ventricle, and sufficiently large pulmonary arteries to minimize mechanical resistance. (See <a class="local">'Lesions treated and rationale'</a> above and <a class="local">'Criteria for Fontan procedure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lesions treated by the Fontan procedure include hypoplastic left heart syndrome, tricuspid atresia, pulmonary atresia with intact ventricular septum, double-inlet left ventricle, and unbalanced atrioventricular canal defects. (See <a class="local">'Lesions treated and rationale'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The most common forms of Fontan procedure are the atriopulmonary connection (no longer being routinely performed due to associated complications) and the cavopulmonary connection. A cavopulmonary connection with an extracardiac conduit has been the dominant Fontan procedure since the year 2000. (See <a class="local">'Surgical technique'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following Fontan procedure, systemic venous pressures are elevated compared with those with a normal biventricular circulation  (<a class="graphic graphic_figure graphicRef95254" href="/z/d/graphic/95254.html" rel="external">figure 5</a>), which leads to many of the complications seen post-Fontan procedure. (See <a class="local">'Fontan "physiology"'</a> above and  <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with prior Fontan operation require lifelong follow-up with a cardiologist experienced in the care of patients with complex congenital heart disease. (See <a class="local">'Long-term follow-up'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with Fontan circulation have restricted exercise capacity that may be due to cardiovascular, pulmonary, and muscular limitations. We suggest periodic cardiopulmonary exercise testing in patients following Fontan operation to exclude chronotropic incompetence, desaturation, or arrhythmias with exercise, and to assess whether exercise limitation is cardiac or pulmonary. Patients with Fontan circulation should be encouraged to participate in an active lifestyle, including routine symptom-limited aerobic activity. (See <a class="local">'Exercise'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy in a patient with prior Fontan operation is considered high risk. Patients with prior Fontan procedure who are contemplating pregnancy should undergo comprehensive preconception assessment and counseling by an adult congenital heart disease specialist. These patients are advised to avoid pregnancy when they have any complications associated with the Fontan procedure. (See <a class="local">'Reproductive issues'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Palliative care is important for patients with Fontan circulation, including timely discussion of transplant timing, end-of-life matters, and advanced care planning (including encouraging completion of advance directives) in an age- and development-appropriate manner. (See <a class="local">'Palliative care'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Operative and long-term survival after Fontan procedure have steadily improved. Patients currently undergoing Fontan procedure are predicted to have a 30-year survival rate of approximately 85 percent. (See <a class="local">'Prognosis after Fontan procedure'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rychik J, Atz AM, Celermajer DS, et al. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation 2019; 140:e234.</a></li><li><a class="nounderline abstract_t">Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73:e81.</a></li><li><a class="nounderline abstract_t">Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26:240.</a></li><li><a class="nounderline abstract_t">Driscoll DJ. Long-term results of the Fontan operation. Pediatr Cardiol 2007; 28:438.</a></li><li><a class="nounderline abstract_t">Shafer KM, Garcia JA, Babb TG, et al. The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation). J Am Coll Cardiol 2012; 60:2115.</a></li><li><a class="nounderline abstract_t">Beghetti M. Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies. Heart 2010; 96:911.</a></li><li><a class="nounderline abstract_t">Goldberg DJ, Dodds K, Rychik J. Rare problems associated with the Fontan circulation. Cardiol Young 2010; 20 Suppl 3:113.</a></li><li><a class="nounderline abstract_t">Schilling C, Dalziel K, Nunn R, et al. The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry. Int J Cardiol 2016; 219:14.</a></li><li><a class="nounderline abstract_t">Akintoye E, Miranda WR, Veldtman GR, et al. National trends in Fontan operation and in-hospital outcomes in the USA. Heart 2019; 105:708.</a></li><li><a class="nounderline abstract_t">Hosein RB, Clarke AJ, McGuirk SP, et al. Factors influencing early and late outcome following the Fontan procedure in the current era. The 'Two Commandments'? Eur J Cardiothorac Surg 2007; 31:344.</a></li><li><a class="nounderline abstract_t">Feinstein JA, Benson DW, Dubin AM, et al. Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol 2012; 59:S1.</a></li><li><a class="nounderline abstract_t">Veldtman GR, Nishimoto A, Siu S, et al. The Fontan procedure in adults. Heart 2001; 86:330.</a></li><li><a class="nounderline abstract_t">Kawashima Y, Kitamura S, Matsuda H, et al. Total cavopulmonary shunt operation in complex cardiac anomalies. A new operation. J Thorac Cardiovasc Surg 1984; 87:74.</a></li><li><a class="nounderline abstract_t">de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988; 96:682.</a></li><li><a class="nounderline abstract_t">Pridjian AK, Mendelsohn AM, Lupinetti FM, et al. Usefulness of the bidirectional Glenn procedure as staged reconstruction for the functional single ventricle. Am J Cardiol 1993; 71:959.</a></li><li><a class="nounderline abstract_t">Marcelletti C, Corno A, Giannico S, Marino B. Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg 1990; 100:228.</a></li><li><a class="nounderline abstract_t">Bridges ND, Lock JE, Castaneda AR. Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk. Circulation 1990; 82:1681.</a></li><li><a class="nounderline abstract_t">Thompson LD, Petrossian E, McElhinney DB, et al. Is it necessary to routinely fenestrate an extracardiac fontan? J Am Coll Cardiol 1999; 34:539.</a></li><li><a class="nounderline abstract_t">Hsu DT, Quaegebeur JM, Ing FF, et al. Outcome after the single-stage, nonfenestrated Fontan procedure. Circulation 1997; 96:II.</a></li><li><a class="nounderline abstract_t">Lemler MS, Scott WA, Leonard SR, et al. Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized study. Circulation 2002; 105:207.</a></li><li><a class="nounderline abstract_t">Anderson PA, Sleeper LA, Mahony L, et al. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008; 52:85.</a></li><li><a class="nounderline abstract_t">Gewillig M. The Fontan circulation. Heart 2005; 91:839.</a></li><li><a class="nounderline abstract_t">Egbe AC, Miranda WR, Anderson JH, Borlaug BA. Hemodynamic and Clinical Implications of Impaired Pulmonary Vascular Reserve in the Fontan Circulation. J Am Coll Cardiol 2020; 76:2755.</a></li><li><a class="nounderline abstract_t">Miranda WR, Jain CC, Borlaug BA, et al. Exercise invasive hemodynamics in adults post-Fontan: A novel tool in understanding functional limitation and liver disease. J Heart Lung Transplant 2022; 41:704.</a></li><li><a class="nounderline abstract_t">Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117:85.</a></li><li><a class="nounderline abstract_t">Ghelani SJ, Harrild DM, Gauvreau K, et al. Comparison Between Echocardiography and Cardiac Magnetic Resonance Imaging in Predicting Transplant-Free Survival After the Fontan Operation. Am J Cardiol 2015; 116:1132.</a></li><li><a class="nounderline abstract_t">Rabbitts JA, Groenewald CB, Mauermann WJ, et al. Outcomes of general anesthesia for noncardiac surgery in a series of patients with Fontan palliation. Paediatr Anaesth 2013; 23:180.</a></li><li><a class="nounderline abstract_t">Egbe AC, Khan AR, Ammash NM, et al. Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures. Heart 2017; 103:1813.</a></li><li><a class="nounderline abstract_t">Driscoll DJ, Danielson GK, Puga FJ, et al. Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle. J Am Coll Cardiol 1986; 7:1087.</a></li><li><a class="nounderline abstract_t">Zellers TM, Driscoll DJ, Mottram CD, et al. Exercise tolerance and cardiorespiratory response to exercise before and after the Fontan operation. Mayo Clin Proc 1989; 64:1489.</a></li><li><a class="nounderline abstract_t">Paridon SM, Mitchell PD, Colan SD, et al. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol 2008; 52:99.</a></li><li><a class="nounderline abstract_t">Harrison DA, Liu P, Walters JE, et al. Cardiopulmonary function in adult patients late after Fontan repair. J Am Coll Cardiol 1995; 26:1016.</a></li><li><a class="nounderline abstract_t">Durongpisitkul K, Driscoll DJ, Mahoney DW, et al. Cardiorespiratory response to exercise after modified Fontan operation: determinants of performance. J Am Coll Cardiol 1997; 29:785.</a></li><li><a class="nounderline abstract_t">McCrindle BW, Williams RV, Mital S, et al. Physical activity levels in children and adolescents are reduced after the Fontan procedure, independent of exercise capacity, and are associated with lower perceived general health. Arch Dis Child 2007; 92:509.</a></li><li><a class="nounderline abstract_t">Rhodes J, Garofano RP, Bowman FO Jr, et al. Effect of right ventricular anatomy on the cardiopulmonary response to exercise. Implications for the Fontan procedure. Circulation 1990; 81:1811.</a></li><li><a class="nounderline abstract_t">Strömvall Larsson E, Eriksson BO. Haemodynamic adaptation during exercise in fontan patients at a long-term follow-up. Scand Cardiovasc J 2003; 37:107.</a></li><li><a class="nounderline abstract_t">Goldberg DJ, Avitabile CM, McBride MG, Paridon SM. Exercise capacity in the Fontan circulation. Cardiol Young 2013; 23:824.</a></li><li><a class="nounderline abstract_t">Shachar GB, Fuhrman BP, Wang Y, et al. Rest and exercise hemodynamics after the Fontan procedure. Circulation 1982; 65:1043.</a></li><li><a class="nounderline abstract_t">Balfour IC, Drimmer AM, Nouri S, et al. Pediatric cardiac rehabilitation. Am J Dis Child 1991; 145:627.</a></li><li><a class="nounderline abstract_t">Egbe AC, Driscoll DJ, Khan AR, et al. Cardiopulmonary exercise test in adults with prior Fontan operation: The prognostic value of serial testing. Int J Cardiol 2017; 235:6.</a></li><li><a class="nounderline abstract_t">Tran DL, Gibson H, Maiorana AJ, et al. Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design. Front Pediatr 2021; 9:799125.</a></li><li><a class="nounderline abstract_t">Nathan AS, Loukas B, Moko L, et al. Exercise oscillatory ventilation in patients with Fontan physiology. Circ Heart Fail 2015; 8:304.</a></li><li><a class="nounderline abstract_t">Jacobsen RM, Ginde S, Mussatto K, et al. Can a home-based cardiac physical activity program improve the physical function quality of life in children with Fontan circulation? Congenit Heart Dis 2016; 11:175.</a></li><li><a class="nounderline abstract_t">Goldberg B, Fripp RR, Lister G, et al. Effect of physical training on exercise performance of children following surgical repair of congenital heart disease. Pediatrics 1981; 68:691.</a></li><li><a class="nounderline abstract_t">Van Hare GF, Ackerman MJ, Evangelista JA, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 2015; 132:e281.</a></li><li><a class="nounderline abstract_t">Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165.</a></li><li><a class="nounderline abstract_t">Canobbio MM, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28:763.</a></li><li><a class="nounderline abstract_t">Hoare JV, Radford D. Pregnancy after fontan repair of complex congenital heart disease. Aust N Z J Obstet Gynaecol 2001; 41:464.</a></li><li><a class="nounderline abstract_t">Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Pregnancy and delivery in women after Fontan palliation. Heart 2006; 92:1290.</a></li><li><a class="nounderline abstract_t">Cauldwell M, Steer PJ, Bonner S, et al. Retrospective UK multicentre study of the pregnancy outcomes of women with a Fontan repair. Heart 2018; 104:401.</a></li><li><a class="nounderline abstract_t">Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49:2303.</a></li><li><a class="nounderline abstract_t">Pundi KN, Pundi K, Johnson JN, et al. Contraception Practices and Pregnancy Outcome in Patients after Fontan Operation. Congenit Heart Dis 2016; 11:63.</a></li><li><a class="nounderline abstract_t">Mair DD, Puga FJ, Danielson GK. The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients. J Am Coll Cardiol 2001; 37:933.</a></li><li><a class="nounderline abstract_t">Driscoll DJ, Offord KP, Feldt RH, et al. Five- to fifteen-year follow-up after Fontan operation. Circulation 1992; 85:469.</a></li><li><a class="nounderline abstract_t">Ono M, Boethig D, Goerler H, et al. Clinical outcome of patients 20 years after Fontan operation--effect of fenestration on late morbidity. Eur J Cardiothorac Surg 2006; 30:923.</a></li><li><a class="nounderline abstract_t">Salazar JD, Zafar F, Siddiqui K, et al. Fenestration during Fontan palliation: now the exception instead of the rule. J Thorac Cardiovasc Surg 2010; 140:129.</a></li><li><a class="nounderline abstract_t">Hirsch JC, Ohye RG, Devaney EJ, et al. The lateral tunnel Fontan procedure for hypoplastic left heart syndrome: results of 100 consecutive patients. Pediatr Cardiol 2007; 28:426.</a></li><li><a class="nounderline abstract_t">Morris SA, Ethen MK, Penny DJ, et al. Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome. Circulation 2014; 129:285.</a></li><li><a class="nounderline abstract_t">Ghanayem NS, Allen KR, Tabbutt S, et al. Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg 2012; 144:896.</a></li></ol></div><div id="topicVersionRevision">Topic 122375 Version 6.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31256636" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30121239" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5089489" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Surgical repair of tricuspid atresia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17768650" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Long-term results of the Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23083785" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20538665" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21087567" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Rare problems associated with the Fontan circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27257850" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30377261" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : National trends in Fontan operation and in-hospital outcomes in the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17236782" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Factors influencing early and late outcome following the Fontan procedure in the current era. The 'Two Commandments'?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22192720" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hypoplastic left heart syndrome: current considerations and expectations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11514490" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The Fontan procedure in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6690861" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Total cavopulmonary shunt operation in complex cardiac anomalies. A new operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3184963" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8465789" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Usefulness of the bidirectional Glenn procedure as staged reconstruction for the functional single ventricle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2143549" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2225370" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10440170" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Is it necessary to routinely fenestrate an extracardiac fontan?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9386120" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Outcome after the single-stage, nonfenestrated Fontan procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11790702" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18598886" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15894794" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The Fontan circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33272370" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hemodynamic and Clinical Implications of Impaired Pulmonary Vascular Reserve in the Fontan Circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35400586" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Exercise invasive hemodynamics in adults post-Fontan: A novel tool in understanding functional limitation and liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18071068" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26251003" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Comparison Between Echocardiography and Cardiac Magnetic Resonance Imaging in Predicting Transplant-Free Survival After the Fontan Operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22998356" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Outcomes of general anesthesia for noncardiac surgery in a series of patients with Fontan palliation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28501797" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3958365" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2513458" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Exercise tolerance and cardiorespiratory response to exercise before and after the Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18598887" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7560594" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Cardiopulmonary function in adult patients late after Fontan repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9091525" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cardiorespiratory response to exercise after modified Fontan operation: determinants of performance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17307794" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Physical activity levels in children and adolescents are reduced after the Fontan procedure, independent of exercise capacity, and are associated with lower perceived general health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2344677" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Effect of right ventricular anatomy on the cardiopulmonary response to exercise. Implications for the Fontan procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12775311" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Haemodynamic adaptation during exercise in fontan patients at a long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24401254" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Exercise capacity in the Fontan circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7074766" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Rest and exercise hemodynamics after the Fontan procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2035491" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Pediatric cardiac rehabilitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28284501" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cardiopulmonary exercise test in adults with prior Fontan operation: The prognostic value of serial testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35071139" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25550441" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Exercise oscillatory ventilation in patients with Fontan physiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26879633" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Can a home-based cardiac physical activity program improve the physical function quality of life in children with Fontan circulation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7312473" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effect of physical training on exercise performance of children following surgical repair of congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26621645" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30165544" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8772769" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pregnancy outcomes after the Fontan repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11787930" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pregnancy after fontan repair of complex congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16449503" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Pregnancy and delivery in women after Fontan palliation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28954835" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Retrospective UK multicentre study of the pregnancy outcomes of women with a Fontan repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17572244" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Outcome of pregnancy in women with congenital heart disease: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26239864" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Contraception Practices and Pregnancy Outcome in Patients after Fontan Operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11693773" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1735145" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Five- to fifteen-year follow-up after Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17074498" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Clinical outcome of patients 20 years after Fontan operation--effect of fenestration on late morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20620378" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Fenestration during Fontan palliation: now the exception instead of the rule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17676374" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The lateral tunnel Fontan procedure for hypoplastic left heart syndrome: results of 100 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24135071" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22795436" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
